Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01983332
Other study ID # 17075
Secondary ID
Status Completed
Phase N/A
First received July 5, 2013
Last updated October 11, 2017
Start date August 2013
Est. completion date August 2017

Study information

Verified date October 2017
Source Texas Woman's University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of this study is to examine the impact of an introduction to the occupation-based theory (MOHO) on the clinical reasoning of therapists working with cancer clients.


Description:

The study will occur at MDACC, a comprehensive cancer center in the Texas Medical Center (TMC) in Houston. The center is the largest freestanding comprehensive cancer center in the world. The facility provides inpatient and outpatient services and supports research and education.

The facility has more than 50 buildings in the greater Houston area and in central Texas. The setting for this study will be the rehabilitation services area on the main campus in the TMC.

There are private offices, conference rooms and treatment areas where video chats and monthly meetings will occur.

The study is projected to occur over a one year period. Sessions will be videotaped (video chats - initial and follow ups and monthly group meetings) for further review. Analysis of the tapes will provide data for further research and education presentations. Sessions will also be audiotaped and transcribed for further review and data analysis purposes. Neither the videotapes nor audiotapes will be shared with anyone at the facility or any uninvolved parties. Audiotapes and videotapes will be stored in locked file cabinets and password protected computers will be used to view and analyze the audio and video tapes. Only the research team will have access to the stored data locked in the file cabinet.


Recruitment information / eligibility

Status Completed
Enrollment 11
Est. completion date August 2017
Est. primary completion date July 2017
Accepts healthy volunteers No
Gender All
Age group 25 Years to 65 Years
Eligibility Inclusion Criteria:

No training in MOHO constructs,English speaking.

Exclusion Criteria:

Training in using MOHO concepts in practice, highly skilled in use of MOHO, and non-English speaking. If a therapist is skilled and knowledgeable of the constructs of MOHO, there will be no way to determine if introduction of the model has impacted a therapist's clinical reasoning. All the materials used for the study will be in English and analysis of data will be conducted by English speaking individuals, therefore the study participants must speak English.

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
United States M.D. Anderson Cancer Center Houston Texas
United States Texas Woman's University Houston Texas

Sponsors (2)

Lead Sponsor Collaborator
Texas Woman's University M.D. Anderson Cancer Center

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Interviews and training sessions-observational analysis of video taped sessions The study will begin with a video chat (20-30 minutes) to attain a baseline of participants understanding of MOHO. An initial video chat interview guide (Appendix B) will be used to facilitate the chat session and a training session on MOHO concepts (4-8 hours) will also be held (Appendix F). The training session is a 6 part overview of the MOHO framework. All following video chats will be conducted using the follow up video chat interview guide (Appendix C). There will be 8 follow up video chat sessions (20-30 minutes) occurring every 6 weeks after the initial training session on MOHO concepts. Video chat sessions will be facilitated by a research team member. There will be 12 monthly group meetings (60-90 minutes) with all participants to allow a time to discuss use of MOHO in practice and troubleshoot issues and offer support in a formal manner. The monthly group meeting will be facilitated by the PI and/or an onsite collaborator. The maximum possible time commitment stands at 1830 30 1/2 hours over course of year
Secondary Observational data analysis-theme sorting until saturation reached This is a qualitative study and data will be analyzed using theme sorting until commonn themes are determined. 1 year
See also
  Status Clinical Trial Phase
Recruiting NCT05346796 - Survivorship Plan HEalth REcord (SPHERE) Implementation Trial N/A
Recruiting NCT05094804 - A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents Phase 1/Phase 2
Completed NCT04867850 - Effect of Behavioral Nudges on Serious Illness Conversation Documentation N/A
Enrolling by invitation NCT04086251 - Remote Electronic Patient Monitoring in Oncology Patients N/A
Completed NCT01285037 - A Study of LY2801653 in Advanced Cancer Phase 1
Completed NCT00680992 - Study of Denosumab in Subjects With Giant Cell Tumor of Bone Phase 2
Completed NCT00062842 - Study of Irinotecan on a Weekly Schedule in Children Phase 1
Active, not recruiting NCT04548063 - Consent Forms in Cancer Research: Examining the Effect of Length on Readability N/A
Completed NCT04337203 - Shared Healthcare Actions and Reflections Electronic Systems in Survivorship N/A
Recruiting NCT04349293 - Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways N/A
Terminated NCT02866851 - Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy N/A
Active, not recruiting NCT05304988 - Development and Validation of the EFT for Adolescents With Cancer
Completed NCT04448041 - CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
Completed NCT00340522 - Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
Recruiting NCT04843891 - Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis. Phase 1
Active, not recruiting NCT03844048 - An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Phase 3
Completed NCT03109041 - Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source Phase 1
Completed NCT03167372 - Pilot Comparison of N-of-1 Trials of Light Therapy N/A
Terminated NCT01441115 - ECI301 and Radiation for Advanced or Metastatic Cancer Phase 1
Recruiting NCT06206785 - Resting Energy Expenditure in Palliative Cancer Patients